BioVie Inc. Class of Warrant or Right, Outstanding
BioVie Inc. (BIVI) had Class of Warrant or Right, Outstanding of 7.90 million shares as of 2026-06-30, per its 10-K filed 2026-08-13.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2026-08-13
- 2026-06-30: Class of Warrant or Right, Outstanding 7.90M shares.
- 2026-03-31: Class of Warrant or Right, Outstanding 7.90M shares.
- 2025-12-31: Class of Warrant or Right, Outstanding 7.90M shares.
- 2025-09-30: Class of Warrant or Right, Outstanding 7.93M shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2026-06-30 | 7.90M shares 10-K · filed 2026-08-13 |
| 2026-03-31 | 7.90M shares S-1/A · filed 2026-08-06 |
| 2025-12-31 | 7.90M shares 10-Q · filed 2026-02-06 |
| 2025-09-30 | 7.93M shares 10-Q · filed 2025-11-10 |
| 2025-06-30 | 960.10K shares S-1/A · filed 2026-08-06 |
| 2025-03-31 | 9.60M shares 10-Q · filed 2025-05-12 |
| 2024-12-31 | 9.60M shares 10-Q · filed 2025-02-11 |
| 2015-03-31 | 5.00M shares 10-Q · filed 2015-05-11 |
| 2014-12-31 | 5.00M shares 10-Q · filed 2015-02-05 |
| 2014-09-30 | 5.00M shares 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |